Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Razzaghi, Hilda ; Kahn, Katherine E. ; Black, Carla L. ; Lindley, Megan C. ; Jatlaoui, Tara C. ; ... More +
Razzaghi, Hilda ; Kahn, Katherine E. ; Black, Carla L. ; Lindley, Megan C. ; Jatlaoui, Tara C. ; Fiebelkorn, Amy Parker ; Havers, Fiona P. ; D’Angelo, Denise V. ; Cheung, Angela ; Ruther, Nicholas A. ; Williams, Walter W. Less -
Description:
Vaccination of pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and Acellular pertussis vaccine (Tdap) can decrease the risk for influenza and pertussis among pregnant women and their infants. The Advisory Committee on Immunization Practices (ACIP) recommends that all women who are or might be pregnant during the influenza season receive influenza vaccine, which can be administered at any time during pregnancy (1). ACIP also recommends that women receive Tdap during each pregnancy, preferably during the early part of gestational weeks 27-36 (2,3). Despite these recommendations, vaccination coverage among pregnant women has been found to be suboptimal with racial/ethnic disparities persisting (4-6). To assess influenza and Tdap vaccination coverage among women pregnant during the 2019-20 influenza season, CDC analyzed data from an Internet panel survey conducted during April 2020. Among 1,841 survey respondents who were pregnant anytime during October 2019-January 2020, 61.2% reported receiving influenza vaccine before or during their pregnancy, an increase of 7.5 percentage points compared with the rate during the 2018-19 season. Among 463 respondents who had a live birth by their survey date, 56.6% reported receiving Tdap during pregnancy, similar to the 2018-19 season (4). Vaccination coverage was highest among women who reported receiving a provider offer or referral for vaccination (influenza = 75.2%; Tdap = 72.7%). Compared with the 2018-19 season, increases in influenza vaccination coverage were observed during the 2019-20 season for non-Hispanic Black (Black) women (14.7 percentage points, to 52.7%), Hispanic women (9.9 percentage points, to 67.2%), and women of other non-Hispanic (other) races (7.9 percentage points, to 69.6%), and did not change for non-Hispanic White (White) women (60.6%). As in the 2018-19 season, Hispanic and Black women had the lowest Tdap vaccination coverage (35.8% and 38.8%, respectively), compared with White women (65.5%) and women of other races (54.0%); in addition, a decrease in Tdap vaccination coverage was observed among Hispanic women in 2019-20 compared with the previous season. Racial/ethnic disparities in influenza vaccination coverage decreased but persisted, even among women who received a provider offer or referral for vaccination. Consistent provider offers or referrals, in combination with conversations culturally and linguistically tailored for patients of all races/ethnicities, could increase vaccination coverage among pregnant women in all racial/ethnic groups and reduce disparities in coverage.
Subjects:
[+]
Adolescent Adult Diphtheria-Tetanus-Acellular Pertussis Vaccines Ethnicity Female Healthcare Disparities Humans Influenza Vaccines Middle Aged Pregnancy Pregnant Women Racial Groups Vaccination Coverage Young Adult
Source:
MMWR Morb Mortal Wkly Rep. 69(39):1391-1397
Pubmed ID:
33001873
Pubmed Central ID:
PMC7537555
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:1cf1c1835d9b9a438bddcd06f763d406ada7dfba3bdf49d1e263adf0f08b2d6a
Download URL:
https://stacks.cdc.gov/view/cdc/95570/cdc_95570_DS1.pdf
File Type:

Supporting Files

• 	mm6939a2-F.gif	gif
  	mm6939a2-F.jpg	jpeg
  	mm6939a2.nxml	xml

More +